Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data

Cancer Treatment Reviews

Volumn 36, Issue 7, 2010, Pages 539-549

  Fiorica, Francesco ^a   Cartei, Francesco ^a   Licata, Anna ^b   Enea, Marco ^b   Ursino, Stefano ^a   Colosimo, Caterina ^a   Cammà, Calogero ^b,c  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Chemoradiotherapy; Meta analysis; Radiotherapy; Rectal carcinoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISTANT METASTASIS; GASTROINTESTINAL TOXICITY; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; REVIEW; SYSTEMATIC REVIEW; ADVERSE EFFECTS; METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PUBLISHING; RADIOTHERAPY; RECTAL NEOPLASMS;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM METASTASIS; PUBLICATION BIAS; RADIOTHERAPY; RECTAL NEOPLASMS;

EID: 77957957407     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.03.002     Document Type: Review

References (46)

1. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18(3):581-592.
2. Wibe A., Møller B., Norstein J., et al. Norwegian Rectal Cancer Group. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002, 45(7):857-866.
3. Lange M.M., Rutten H.J., van de Velde C.J.K. One hundred years of curative surgery for rectal cancer: 1908-2008. EJSO 2009, 35:456-463.
4. Nagtegaal I.D., Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 2008, 26:303-312.
5. Cammà C., Giunta M., Fiorica F., et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000, 284(8):1008-1015.
6. Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001, 20:1291-1304.
7. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
8. Boulis-Wassif S., Gerard A., Loygue J., et al. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984, 53(9):1811-1818.
9. Frykholm G.J., Påhlman L., Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001, 50(2):427-434.
10. Bosset J.F., Calais G., Daban A., et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004, 40(2):219-224.
11. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72(1):15-24.
12. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355(11):1114-1123.
13. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006, 93(10):1215-1223.
14. Gérard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24(28):4620-4625.
15. Rouanet P., Rivoire M., Lelong B., et al. Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma. A French multicenter prospective trial: GRECCAR 1. J Clin Oncol 2006, 18S:3527.
16. Braendengen M., Tveit K.M., Berglund A., et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008, 26(22):3687-3694.
17. Gastrointestinal Tumor Study Group Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985, 312:1465-1472.
18. Mansour E.G., Lefkopoulou M., Johnson R., et al. A comparison of postoperative adjuvant chemotherapy, radiotherapy or combination therapy in potentially curable resectable rectal carcinoma. An ECOG study EST 4276. Proc Ann Meet Am Soc Clin Oncol 1991, 10:154. Abstract 484.
19. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991, 324(11):709-715.
20. Cafiero F., Gipponi M., Peressini A., et al. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol 2000, 75(2):80-88.
21. Cafiero F., Gipponi M., Lionetto R. P.A.R. Cooperative Study Group. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. J Surg Oncol 2003, 83(3):140-146.
22. Taher A.N., El-Baradie M.M., Nasr A.M., et al. Locally advanced rectal carcinoma: preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study. J Egypt Natl Canc Inst 2006, 18(3):233-243.
23. Sebag-Montefiore D., Stephens R.J., Steele R., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373(9666):811-820.
24. Sauer R., Becker H., Hohenberger W., et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351(17):1731-1740.
25. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999, 354(9193):1896-1900.
26. Corrao S., Colomba D., Arnone S., et al. Improving efficacy of PubMed clinical queries for retrieving scientifically strong studies on treatment. J Am Med Inform Assoc 2006, 13(5):485-487.
27. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
28. Bañares R., Albillos A., Rincón D., Alonso S., González M., Ruiz-del-Arbol L., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002, 35:609-615.
29. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
30. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
31. Jaeschke R., Oxman A.D., Guyatt G.H. To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med 1990, 88(3):279-286.
32. Olkin I. Diagnostic statistical procedures in medical meta-analyses. Stat Med 1999, 18(17-18):2331-2341.
33. Johnstone P.A., Rohde D.C., Saunders E.L., Mitchell J.B. Combining intraoperative and conventional external radiotherapy doses: a biology-based approach. Front Radiat Ther Oncol 1997, 31:18-21.
34. Hedges L.V., Olkin I. Statistical methods for meta-analysis 1985, Academic Press, New York.
35. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
36. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
37. Tveit K.M., Guldvog I., Hagen S., et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 1997, 84(8):1130-1135.
38. Ragnhammar P., Hafström L., Nygren P., et al. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001, 40(2-3):282-308.
39. Köckerling F., Reymond M.A., Altendorf-Hofmann A., et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998, 16(1):324-329.
40. Cella L., Ciscognetti N., Martin G., et al. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning. Med Dosim 2009, 34(1):75-81.
41. Michalski J.M., Winter K., Purdy J.A., et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys 2005, 62(3):706-713.
42. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994, 331:502-507.
43. Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 1982, 69(10):613-616.
44. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986, 1(8496):1479-1482.
45. Martling A., Cedermark B., Johansson H., et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002, 89:1008-1013.
46. Kim Y.W., Kim N.K., Min B.S., et al. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 2009, 249(6):965-972.